The recording of adverse events from psychological treatments in clinical trials: evidence from a review of NIHR-funded trials

被引:114
|
作者
Duggan, Conor [1 ,2 ]
Parry, Glenys [3 ]
McMurran, Mary [1 ]
Davidson, Kate [4 ]
Dennis, Jane [5 ]
机构
[1] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2TU, England
[2] Head Res & Dev, Borehamwood WD6 JN, Herts, England
[3] Univ Sheffield, Sch Hlth & Related Res, Ctr Psychol Serv Res, Sheffield S1 4DA, S Yorkshire, England
[4] Univ Glasgow, Gartnavel Royal Hosp, Coll Med Vet & Life Sci, Inst Hlth & Wellbeing, Glasgow G12 0XH, Lanark, Scotland
[5] Social Well Fare Grp, Bristol BS6 7DB, Avon, England
来源
TRIALS | 2014年 / 15卷
基金
美国国家卫生研究院;
关键词
Harm; Adverse events; Psychological interventions; Clinical trials; RANDOMIZED-TRIALS; PSYCHOTHERAPY; EXTENSION; THERAPY; SAFETY; HARMS;
D O I
10.1186/1745-6215-15-335
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: There is a concern in the literature that harm from interventions is insufficiently documented in clinical trials in general, and in those assessing psychological treatments in particular. A recent decision by a trial steering committee to stop recruitment into a randomized controlled trial (RCT) of a psychological intervention for personality disorder led to an investigation of the recording of harm in trials funded by the National Institute for Health Research (NIHR). Methods: The protocols and final reports of all 82 NIHR trials funded between 1995 and 2013 were examined for the reporting of adverse events. These were subdivided by category of intervention. Results: None of the psychological intervention trials mentioned the occurrence of an adverse event in their final report. Trials of drug treatments were more likely to mention adverse events in their protocols compared with those using psychological treatments. When adverse events were mentioned, the protocols of psychological interventions relied heavily on severe adverse events guidelines from the National Research Ethics Service (NRES), which were developed for drug rather than psychological interventions and so may not be appropriate for the latter. Conclusions: This survey supported the belief that the reporting of adverse events in psychological treatments is weak and the criteria used may not be appropriate. Recommendations are made as to how current practice might be improved.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Gastrointestinal and cardiovascular adverse events of NSAIDS in children clinical trials (RCTs): a systematic review
    Balzarin, M.
    Pariente, A.
    Salvo, F.
    Giaquinto, C.
    Sturkenboom, M.
    Fourrier-Reglat, A.
    Zulian, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 423 - 423
  • [42] A systematic review of adverse events in placebo groups of anti-migraine clinical trials
    Amanzio, Martina
    Corazzini, Luca Latini
    Vase, Lene
    Benedetti, Fabrizio
    PAIN, 2009, 146 (03) : 261 - 269
  • [43] Is There a Higher Risk of CNS Adverse Events for PI Monotherapy Versus Triple Therapy? A Review of Results From Randomized Clinical Trials
    Powderly, William
    Hill, Andrew
    Moecklinghoff, Christiane
    HIV CLINICAL TRIALS, 2014, 15 (03): : 79 - 86
  • [44] Amyotrophic lateral sclerosis: an update on treatments from clinical trials
    Ray Wynford-Thomas
    Neil P. Robertson
    Journal of Neurology, 2023, 270 : 1187 - 1189
  • [45] Exercise Interventions for Autistic People: An Integrative Review of Evidence from Clinical Trials
    Rivera, Rachel A.
    Robertson, Meredith C.
    Mccleery, Joseph P.
    CURRENT PSYCHIATRY REPORTS, 2025, : 286 - 306
  • [46] Amyotrophic lateral sclerosis: an update on treatments from clinical trials
    Wynford-Thomas, Ray
    Robertson, Neil P. P.
    JOURNAL OF NEUROLOGY, 2023, 270 (02) : 1187 - 1189
  • [47] Eliciting adverse effects data from participants in clinical trials
    Allen, Elizabeth N.
    Chandler, Clare I. R.
    Mandimika, Nyaradzo
    Leisegang, Cordelia
    Barnes, Karen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [48] Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review
    Williams, Mark R.
    McKeown, Andrew
    Pressman, Zachary
    Hunsinge, Matthew
    Lee, Kendrick
    Coplan, Paul
    Gilron, Ian
    Katz, Nathaniel P.
    McDermott, Michael P.
    Raja, Srinivasa N.
    Rappaport, Bob A.
    Rowbotham, Michael C.
    Turk, Dennis C.
    Dworkin, Robert H.
    Smith, Shannon M.
    JOURNAL OF PAIN, 2016, 17 (11): : 1137 - 1149
  • [49] Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome
    Tolbert, Dwain
    Harris, Stuart I.
    Bekersky, Ihor
    Lee, Deborah
    Isojarvi, Jouko
    EPILEPSY & BEHAVIOR, 2014, 37 : 11 - 15
  • [50] PROFILING ADVERSE EVENTS IN MULTIPLE MYELOMA: INSIGHTS FROM CLINICAL TRIALS VIA LARGE LANGUAGE MODELS
    Paek, H.
    Lee, K.
    Datta, S.
    Huang, L. C.
    Higashi, J.
    Ofoegbu, N.
    He, L.
    Lin, B.
    Wang, J.
    Wang, X.
    VALUE IN HEALTH, 2024, 27 (06) : S18 - S18